Day One Biopharmaceuticals (DAWN) December 10 and 11 calls active
Tweet
Share
E-mailGet Alerts DAWN Hot Sheet
Join SI Premium – FREE
Day One Biopharmaceuticals (NASDAQ: DAWN) 30-day call option implied volatility is at 141; compared to its 52-week range of 44 to 178 with a focus on December 10 and 11 calls as share price up 8.2%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- Black Rock Coffee Bar, Inc. (BRCB) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
